Medical Science Liaison (MSL) / Senior Medical Science Liaison (Sr. MSL), Oncology - Massachusetts; Field-based
Eisai US
Summary
The Medical Science Liaison (MSL) / Senior Medical Science Liaison (Sr. MSL) is a field-facing representative of US Medical Affairs with a primary responsibility of engaging in the exchange of scientific data and other medical and/or scientific information with external customers (healthcare providers, researchers, professional organization leadership, and population-based decision makers) in the areas of Eisai's interest.
Job description
Essential Functions
Product/Therapeutic Area Support to External Stakeholders
- Act as the primary clinical/scientific resource to Healthcare Providers (HCPs) in the territory for information pertaining to disease state and Eisai's product(s) to ensure awareness and understanding.
- Serve as a conduit for accurate and updated clinical, scientific and medical information between Key Opinion Leaders (KOLs)/investigators and the company's Medical Affairs and development groups.
- Establish, foster, cultivate and maintain peer relationships with KOLs in the therapeutic areas in which Eisai has current and future interests.
- Share knowledge and participate in scientific exchanges and interactions with identified KOLs.
- Present clinical, scientific and economic data on Eisai's products and relevant therapeutic areas to population-based decision-makers, as requested.
- Support assigned professional congresses in accordance with MSL plan.
- Be prepared to lead congress coverage efforts, including coordination of all MSL/Sr. MSL activities, as required and assigned by the management.
- Identify and report key scientific, clinical and research insights from KOLs to Medical Affairs.
- Develop, implement and present to management plans to support Medical Affairs strategic direction for assigned territory.
Training/Education Resource
- Maintain and demonstrate thorough and up-to-date knowledge of disease state, study methodology, clinical information, and product data.
- Demonstrate full knowledge of and ability to execute on approved medical platforms/strategies and MSL initiatives.
- Serve as technical/scientific subject matter resource to Eisai commercial personnel, if requested.
- Teach, coach and mentor new or less experienced MSLs; assist with supervision/performance evaluation; assume responsibility for special projects.
- Provide valuable contributions to the organization including leadership and strategic planning.
Research Support
- Facilitate review and follow up of submitted Investigator-Initiated Studies (IISs) and assist with Eisai sponsored trials.
- Serve as primary contact to external investigators who submit IISs.
- The MSL may also be involved with providing recommendations for site selection and scientific expertise to Investigators involved in company sponsored post-marketing studies.
Professional Organization Support
Lead field medical efforts in support of Eisai's collaboration and interactions with professional organizations/societies & advocacy groups, as required.
Requirements
- Advanced, terminal Doctorate level (D-level) degree in medical or health sciences (e.g. MD, PhD, PharmD, DPH, EdD)
- For MSL: 0-3 years of experience in the pharma/biotech industry/clinical pharmacist/research/ related experience in a scientific or clinical setting, preferably as MSL
- For Sr. MSL: minimum of 3 years MSL experience in Oncology/Hematology
- Strong broad-based scientific and pharmaceutical knowledge
- Clinical trial development and drug launch experience is strongly preferred
- Knowledge of treatment guidelines, clinical research processes, FDA regulations and OIG guidelines are required
- Knowledge and experience within Eisai desired therapeutic area(s) and ability to communicate with confidence and accuracy across multiple disease states
- Established relationships with key opinion leaders and knowledge of institutions in therapeutic areas of interest
- Excellent presentation and teaching skills
- Strong overall written and verbal communication skills
- Demonstrated ability to assess issues and think strategically
- Demonstrated ability and experience working cross-functionally
- Demonstrated ability to anticipate, organize, plan and handle multiple changing priorities
- Demonstrated ability to work independently and not requiring close supervision while adhering to Medical Affairs strategic direction
- Ability and interest in coaching and mentoring less experienced MSLs
- Ability to lead and motivate team members without a direct reporting relationship
- Ability and interest in leading and participating in projects while effectively balancing projects with field work
- Demonstrated ability to analyze complex situations and proactively identify opportunities/issues; effectively solve problems that cross functional boundaries
- Committed to the concept of team and working within the framework of the Medical Affairs Department and Eisai organization, including as it pertains to compliance with policies, systems and practices
- Sound computer skills including applications for word processing, producing slide materials and working with spreadsheets
- Previous established relationships with KOLs in Oncology/Hematology
- Possesses an understanding of the pharmaceutical corporate environment and appreciation for commercial operations, including marketing and sales strategies
- Capable of engaging in frequent business travel (approximately 60% of time), including air travel, ability to travel overnight and occasionally on weekends
- Possesses and maintains a valid driver's license
Benefits
- Annual Incentive Plan
- Long Term Incentive Plan
- Company employee benefit programs
Company overview
Eisai US is the American pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., a global pharmaceutical company founded in 1941. Headquartered in Nutley, New Jersey, Eisai US operates with a passionate commitment to patient care through its human health care (hhc) philosophy, which places patients and their families at the forefront of all business decisions. The company focuses on two primary therapeutic areas: oncology and neurology, with particular emphasis on dementia-related diseases and neurodegenerative disorders. Eisai US maintains a fully integrated pharmaceutical business model with end-to-end capabilities spanning discovery, development, and marketing. The organization operates commercial and clinical development organizations in New Jersey, discovery labs in Massachusetts and Pennsylvania, and global demand chain operations in Maryland and North Carolina. Notable products in its portfolio include Leqembi (lecanemab) for Alzheimer's disease, Lenvima (lenvatinib) for various cancers, and Aricept (donepezil) for Alzheimer's treatment. With approximately 1,001-5,000 employees in the United States, Eisai US represents a significant presence in the American pharmaceutical landscape, dedicated to addressing unmet medical needs through innovative therapies and comprehensive patient support programs.